Icon PLC
- Last sale
- Nov 12, 2026 · +0.49%
- Market cap
- —
- no share count on file
- Filings
- 845
Q3 2026+0.8% FY25 yoy
Q3 2026−69.0% FY25 yoy
Q3 2026−57.1% FY25 yoy
Q3 2026derived−22.9% FY25 yoy
Q3 2026−67.4% FY25 yoy
Q3 2026+20.1% FY25 yoy
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $8,251,340,000 | reported | |
| FY 2024 | 2024-12-31 | $8,188,990,000 revised | reported | |
| FY 2023 | 2023-12-31 | $8,054,926,000 revised | reported | |
| FY 2022 | 2022-12-31 | $7,741,386,000 | reported | |
| FY 2021 | 2021-12-31 | $5,480,826,000 | reported | |
| FY 2020 | 2020-12-31 | $2,797,288,000 | reported | |
| FY 2019 | 2019-12-31 | $2,805,839,000 | reported | |
| FY 2018 | 2018-12-31 | $2,595,777,000 | reported | |
| FY 2017 | 2017-12-31 | $1,758,439,000 | reported | |
| FY 2016 | 2016-12-31 | $1,666,487,000 | reported | |
| FY 2015 | 2015-12-31 | $1,574,978,000 | reported | |
| FY 2014 | 2014-12-31 | $1,503,316,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $750.00M | $750.00M | — | 76.57M sh | −5.2% | 87.0% |
| FY2024 | — | $500.00M | $500.00M | — | 80.76M sh | −2.1% | 44.7% |
| FY2023 | — | $0.00 | $0.00 | — | 82.50M sh | +0.9% | 0.0% |
| FY2022 | — | $99.98M | $99.98M | — | 81.72M sh | +0.2% | 23.7% |
| FY2021 | — | $0.00 | $0.00 | — | 81.55M sh | +54.5% | 0.0% |
Segments
Geography
LineFY2025ShareChange
Ireland$3.18B39%+17.7%
United States$2.52B31%−15.4%
Rest of Europe$1.59B19%+2.0%
Rest of World$951.90M12%+1.0%
Other———
Total$8.25B
Commercial physical & biological research
Icon PLC is the 2nd largest of the 17 covered companies the SEC files under this code, by revenue. SIC 8731
CompanyRevenueGrowthNet marginMarket cap
IQVIQVIA Holdings Inc.$16.3B5.9%8.3%$44.7B
ICLRIcon PLC (this company)$8.3B0.8%2.8%—
INCYIncyte Corp$5.1B21.2%25.0%$24.8BCRLCharles River Laboratories International, Inc.$4.0B0.9%3.6%$16.9BMEDPMedpace Holdings, Inc.$2.5B20.0%17.8%$18.4BNRCNRC Health$137.4M4.0%8.4%$566.4MMXCTMaxcyte, Inc.$33.0M14.5%135.1%$121.8MOABIOmniAb, Inc.$18.7M29.3%347.0%$721.3MFOXOFoxo Technologies Inc.$16.4M304.0%75.9%—Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Icon PLC · CIK 1060955 · Engraved from SEC EDGAR